MENU
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Neurogene (NGNE) Earnings Date & Reports
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning)... Show more
A.I. Advisor
published Earnings
NGNE is expected to report earnings to rise 41.90% to -149 cents per share on November 12
Q3'26
Est.
$-1.49
Q2'26
Beat
by $0.38
Q1'26
Missed
by $0.12
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.19
The last earnings report on August 11 showed earnings per share of -104 cents, beating the estimate of -142 cents. With 66.08K shares outstanding, the current market capitalization sits at 521.90M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
131
Web
https://www.neurogene.com